The present review details a chronological description of the events that took place during
the development of mesoporous materials, their different synthetic routes and their use as …

In recent years, the development of nanoparticles has expanded into a broad range of
clinical applications. Nanoparticles have been developed to overcome the limitations of free …

Developing ultrasensitive and highly selective biosensors is significant for the early
diagnosis of cancers and monitoring of the treatment process of cancer patients. Metal …

Extracellular vesicles (EVs) in human blood are a potential source of biomarkers. To which
extent anticoagulation affects their concentration, cellular origin and protein composition is …

Both passive and active microfluidic chips are used in many biomedical and chemical
applications to support fluid mixing, particle manipulations, and signal detection. Passive …

Nanoparticles-based drug delivery systems have attracted significant attention in biomedical
fields because they can deliver loaded cargoes to the target site in a controlled manner …

In vitro diagnosis (IVD) is pivotal in modern medicine, enabling early disease detection and
treatment optimization. Omics technologies, particularly proteomics and metabolomics, offer …

Over the last decade nanomaterials have had a major impact on human health for the early
detection and treatment of many diseases. The future success of clinically translatable …

Traditional drugs are facing bottlenecks of lower solubility, absorption, and especially the
inefficient organs or cells targeting during the precision medicine era. It is urgently needed to …

Nanomedicine is recognized as a promising agent for diverse biomedical applications;
however, its safety and efficiency in clinical practice remains to be enhanced. A priority issue …